Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
Dollar change
Percentage change
IndexS&P 500 P/E23.98 EPS (ttm)0.80 Insider Own19.13% Shs Outstand1.89B Perf Week-0.83%
Market Cap36.65B Forward P/E15.27 EPS next Y1.25 Insider Trans0.00% Shs Float1.55B Perf Month-9.03%
Income1.52B PEG13.40 EPS next Q0.26 Inst Own89.12% Short Float1.44% Perf Quarter-5.06%
Sales15.44B P/S2.37 EPS this Y-10.15% Inst Trans- Short Ratio1.17 Perf Half Y-16.67%
Book/sh5.69 P/B3.36 EPS next Y8.15% ROA- Short Interest22.34M Perf Year-
Cash/sh0.55 P/C34.51 EPS next 5Y1.79% ROE- 52W Range17.82 - 27.80 Perf YTD-11.10%
Dividend Est.0.80 (4.19%) P/FCF- EPS past 5Y4.33% ROI8.16% 52W High-31.14% Beta-
Dividend TTM0.60 (3.13%) Quick Ratio0.78 Sales past 5Y1.93% Gross Margin55.81% 52W Low7.41% ATR (14)0.39
Dividend Ex-DateFeb 13, 2024 Current Ratio1.14 EPS Y/Y TTM- Oper. Margin18.22% RSI (14)37.21 Volatility1.76% 1.89%
Employees22200 Debt/Eq0.77 Sales Y/Y TTM- Profit Margin9.87% Recom2.00 Target Price22.88
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q-13.22% Payout66.67% Rel Volume0.86 Prev Close18.92
Sales Surprise-3.10% EPS Surprise9.54% Sales Q/Q-2.60% EarningsFeb 08 BMO Avg Volume19.14M Price19.14
SMA20-2.90% SMA50-7.10% SMA200-13.50% Trades Volume16,446,762 Change1.16%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Initiated Piper Sandler Neutral $20
Sep-11-23Upgrade Deutsche Bank Hold → Buy $27
Sep-07-23Initiated Canaccord Genuity Buy $28
Sep-06-23Initiated Argus Hold
Aug-24-23Upgrade Goldman Neutral → Buy $29
Jul-25-23Initiated Edward Jones Buy
Jun-01-23Initiated HSBC Securities Hold $27
May-30-23Initiated UBS Neutral $28
May-30-23Initiated RBC Capital Mkts Outperform $29
May-30-23Initiated JP Morgan Overweight $29
Feb-16-24 05:19PM
Feb-13-24 08:00AM
Feb-08-24 02:21PM
06:58AM Loading…
Jan-25-24 08:30AM
Jan-24-24 07:00AM
Jan-10-24 05:49PM
Jan-05-24 08:00AM
Dec-20-23 11:30AM
Dec-19-23 04:37PM
06:56AM Loading…
Dec-11-23 06:56AM
Dec-06-23 02:30PM
Dec-01-23 08:59AM
Nov-30-23 09:06AM
Nov-28-23 04:32PM
Nov-24-23 06:45PM
Nov-21-23 07:06PM
Nov-17-23 11:14AM
Nov-13-23 11:11AM
Nov-08-23 08:45AM
Nov-03-23 09:11AM
01:10PM Loading…
Oct-30-23 01:10PM
Oct-29-23 03:38PM
Oct-27-23 07:00PM
Oct-26-23 04:08PM
Oct-24-23 06:30PM
Oct-20-23 03:28PM
Oct-17-23 02:09PM
Oct-14-23 09:00AM
Oct-13-23 09:42PM
Oct-12-23 07:27PM
Sep-24-23 07:00AM
Sep-22-23 06:30AM
Sep-12-23 06:04PM
Sep-11-23 09:43AM
Sep-07-23 10:09AM
Sep-06-23 11:13AM
Sep-04-23 05:30AM
Aug-24-23 11:03AM
Aug-23-23 06:25AM
Aug-21-23 06:00PM
Aug-18-23 01:32PM
Aug-16-23 06:52PM
Aug-09-23 06:42PM
Aug-07-23 05:10PM
Jul-31-23 07:20PM
Jul-24-23 11:52AM
Jul-20-23 03:54PM
Jul-18-23 12:33AM
Jun-29-23 04:49PM
Jun-06-23 04:30PM
May-31-23 07:00AM
May-29-23 07:15PM
May-15-23 06:54AM
May-08-23 04:33PM
May-05-23 10:26AM
May-04-23 05:13PM
Kenvue, Inc. is a consumer health company. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment focuses on oral care, baby care, women's health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ruh PaulChief Financial OfficerFeb 13Option Exercise0.002,600027,614Feb 15 05:29 PM
Howlett HeatherVP & Chief Accounting OfficerFeb 13Option Exercise0.001,55601,556Feb 15 05:28 PM
Stevens MeredithChief Operations OfficerFeb 13Option Exercise0.003,215032,861Feb 15 05:28 PM
Xie BingGroup President APACFeb 13Option Exercise0.004,134022,746Feb 15 05:28 PM
Lawson CarltonGroup President EMEA & LAFeb 13Option Exercise0.004,519018,280Feb 15 05:28 PM
Mongon ThibautChief Executive OfficerFeb 13Option Exercise0.008,4380116,522Feb 15 05:29 PM
Alvarado LuaniChief People OfficerFeb 13Option Exercise0.001,830015,362Feb 15 05:27 PM
Tillett CarolineChief Scientific OfficerFeb 13Option Exercise0.003,000021,787Feb 15 05:27 PM
Meurer JanGroup President, North AmericaFeb 13Option Exercise0.002,119016,782Feb 15 05:27 PM
Orlando MatthewGeneral CounselFeb 13Option Exercise0.001,371011,632Feb 15 05:27 PM
England CharmaineChief Growth OfficerFeb 13Option Exercise0.001,296019,840Feb 15 05:28 PM
Tavares BernardoChief Tech & Data OfficerFeb 13Option Exercise0.001,34107,414Feb 15 05:26 PM
Stevens MeredithChief Operations OfficerFeb 08Option Exercise0.0039,530031,943Feb 12 07:15 PM
Tillett CarolineChief Scientific OfficerFeb 08Option Exercise0.0027,996021,321Feb 12 07:14 PM
Orlando MatthewGeneral CounselFeb 08Option Exercise0.0013,905011,070Feb 12 07:14 PM
Mongon ThibautChief Executive OfficerFeb 08Option Exercise0.00202,9470179,515Feb 12 07:14 PM
Xie BingGroup President APACFeb 08Option Exercise0.0037,797028,781Feb 12 07:15 PM
Tavares BernardoChief Tech & Data OfficerFeb 08Option Exercise0.009,99307,608Feb 12 07:13 PM
Lawson CarltonGroup President EMEA & LAFeb 08Option Exercise0.0013,068013,995Feb 12 07:13 PM
Alvarado LuaniChief People OfficerFeb 08Option Exercise0.0020,091015,298Feb 12 07:13 PM
Meurer JanGroup President, North AmericaFeb 08Option Exercise0.0023,358017,787Feb 12 07:13 PM
Ruh PaulChief Financial OfficerFeb 08Option Exercise0.0036,611027,877Feb 12 07:14 PM
England CharmaineChief Growth OfficerFeb 08Option Exercise0.0019,661018,706Feb 12 07:12 PM
ALLISON RICHARD E JRDirectorAug 30Buy22.965,598128,52425,598Aug 31 04:25 PM
ALLISON RICHARD E JRDirectorMay 11Buy26.2620,000525,23220,000May 12 04:14 PM